Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

652
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
652
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

623
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
623
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

531
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
531
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

903
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
903
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

615
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
615

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D and its role in human milk oligosaccharide production.

The Journal of steroid biochemistry and molecular biology·2026
Same author

Efforts to Enhance Recruitment and Engagement of Caregivers from Medically Underserved Communities in a Randomized Controlled Trial of a Vaccine Promotion App.

Journal of clinical and translational science·2026
Same author

Corrigendum to "Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children" [Vaccine 61 (2025) 127245].

Vaccine·2025
Same author

Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children.

Vaccine·2025
Same author

Erratum: "Impact of Skin Care Products on Phthalates and Phthalate Replacements in Children: The ECHO-FGS".

Environmental health perspectives·2024
Same author

Impact of Skin Care Products on Phthalates and Phthalate Replacements in Children: the ECHO-FGS.

Environmental health perspectives·2024

Related Experiment Video

Updated: Dec 16, 2025

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.8K

Opioids or Steroids for Pneumonia or Sinusitis.

Karina G Phang1, James R Roberts2, Myla Ebeling2

  • 1Geisinger Medical Center, Danville, Pennsylvania; and kphang@geisinger.edu.

Pediatrics
|July 4, 2020
PubMed
Summary

Children with pneumonia or sinusitis were more likely to receive opioid and corticosteroid prescriptions during emergency department (ED) visits compared to ambulatory care. This highlights a disparity in prescription patterns based on care location for pediatric respiratory infections.

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.4K
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
12:27

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

17.1K

Related Experiment Videos

Last Updated: Dec 16, 2025

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.8K
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.4K
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
12:27

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

17.1K

Area of Science:

  • Pediatric Medicine
  • Pharmacology
  • Health Services Research

Background:

  • Opioid and corticosteroid prescriptions are common for pediatric respiratory conditions.
  • The location of care may influence prescription patterns for these medications.

Purpose of the Study:

  • To compare the frequency of opioid and corticosteroid prescriptions for children with pneumonia or sinusitis based on the care setting.
  • To investigate potential disparities in medication prescribing for pediatric respiratory infections.

Main Methods:

  • Analysis of South Carolina Medicaid claims data from 2016 for children aged 5-18 years.
  • Comparison of prescription rates for pneumonia and sinusitis visits across emergency departments (ED), urgent care, and ambulatory settings.

Main Results:

  • Children with pneumonia or sinusitis were significantly more likely to receive opioid and corticosteroid prescriptions in the ED compared to ambulatory settings.
  • Logistic regression showed increased odds of receiving opioids (aOR 4.69 for pneumonia, 4.02 for sinusitis) and steroids (aOR 1.67 for pneumonia, 3.05 for sinusitis) in the ED.

Conclusions:

  • School-aged children receive opioid and steroid prescriptions more frequently in the ED than in ambulatory settings for pneumonia or sinusitis.
  • Care location is a significant factor influencing the prescribing of opioids and corticosteroids for common pediatric respiratory conditions.